Trade Summary

3 days ago, Washburn Theodore James Jr., serving as Principal Accounting Officer at Agios Pharmaceuticals, Inc. (AGIO), sold 5,272 shares at $28.88 per share, for a total transaction value of $152,255.00. Following this transaction, Washburn Theodore James Jr. now holds 868 shares of AGIO.

This sale represents a 86.00% decrease in Washburn Theodore James Jr.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 2 days after the trade was made.

Agios Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.